{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:45:17Z","timestamp":1793274317570,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10067-022-06338-1","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T06:03:14Z","timestamp":1660975394000},"page":"3565-3572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-5912","authenticated-orcid":false,"given":"Camila Andrea","family":"Guerrero-Berm\u00fadez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-3514","authenticated-orcid":false,"given":"Andr\u00e9s Felipe","family":"Cardona-Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3830-3977","authenticated-orcid":false,"given":"Edwin Jes\u00fas","family":"Ariza-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4757-504X","authenticated-orcid":false,"given":"Juan Ignacio","family":"Arostegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-9672","authenticated-orcid":false,"given":"Anna","family":"Mensa-Vilaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8210-1929","authenticated-orcid":false,"given":"Jordi","family":"Yague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0647-0906","authenticated-orcid":false,"given":"Gloria","family":"V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5003-0721","authenticated-orcid":false,"given":"Carlos Horacio","family":"Mu\u00f1oz-Vahos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,20]]},"reference":[{"key":"6338_CR1","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W et al (2020) Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med 383:2628\u20132638. https:\/\/doi.org\/10.1056\/NEJMoa2026834","journal-title":"N Engl J Med"},{"key":"6338_CR2","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1182\/blood.2021011455","volume":"137","author":"PC Grayson","year":"2021","unstructured":"Grayson PC, Patel BA, Young NS (2021) VEXAS syndrome. Blood 137:3591\u20133594. https:\/\/doi.org\/10.1182\/blood.2021011455","journal-title":"Blood"},{"key":"6338_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1182\/blood-2020-141949","volume":"136","author":"DB Beck","year":"2020","unstructured":"Beck DB, Wu Z, Patel BA, Ferrada MA, Sikora KA, Ombrello A et al (2020) Somatic mutations in a single residue of UBA1 cause vexas, a severe adult-onset rheumatic disease associated with myeloid dysplasia. Blood 136:36\u201337. https:\/\/doi.org\/10.1182\/blood-2020-141949","journal-title":"Blood"},{"key":"6338_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06211-1","author":"A Nune","year":"2022","unstructured":"Nune A, Iyengar KP, Barman B, Manzo C (2022) The VEXAS syndrome from rheumatology perspective: genomic DNA sequencing as available blueprint for diagnosing rheumatic diseases with overlapping haematological or dermatological findings. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-022-06211-1","journal-title":"Clin Rheumatol"},{"key":"6338_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1053\/j.seminhematol.2021.10.001","volume":"58","author":"JA Poulter","year":"2021","unstructured":"Poulter JA, Savic S (2021) Genetics of somatic auto-inflammatory disorders. Semin Hematol 58:212\u2013217. https:\/\/doi.org\/10.1053\/j.seminhematol.2021.10.001","journal-title":"Semin Hematol"},{"key":"6338_CR6","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1093\/rheumatology\/keab392","volume":"60","author":"T Barba","year":"2021","unstructured":"Barba T, Jamilloux Y, Durel CA, Bourbon E, Mestrallet F, Sujobert P et al (2021) VEXAS syndrome in a woman. Rheumatology (Oxford) 60:e402\u2013e403. https:\/\/doi.org\/10.1093\/rheumatology\/keab392","journal-title":"Rheumatology (Oxford)"},{"key":"6338_CR7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3324\/haematol.2021.280238","volume":"107","author":"RJ Stubbins","year":"2022","unstructured":"Stubbins RJ, McGinnis E, Johal B, Chen LY, Wilson L, Cardona DO et al (2022) VEXAS syndrome in a female patient with constitutional 45, X (Turner syndrome). Haematologica 107:1011\u20131013. https:\/\/doi.org\/10.3324\/haematol.2021.280238","journal-title":"Haematologica"},{"key":"6338_CR8","doi-asserted-by":"publisher","first-page":"E524","DOI":"10.1503\/cmaj.211770","volume":"194","author":"RJ Stubbins","year":"2022","unstructured":"Stubbins RJ, Cherniawsky H, Chen LYC, Nevill TJ (2022) Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. CMAJ 194:E524-e527. https:\/\/doi.org\/10.1503\/cmaj.211770","journal-title":"CMAJ"},{"key":"6338_CR9","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1182\/blood.2020010286","volume":"137","author":"JA Poulter","year":"2021","unstructured":"Poulter JA, Collins JC, Cargo C, De Tute RM, Evans P, Ospina Cardona D et al (2021) Novel somatic mutations in UBA1 as a cause of VEXAS syndrome. Blood 137:3676\u20133681. https:\/\/doi.org\/10.1182\/blood.2020010286","journal-title":"Blood"},{"key":"6338_CR10","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1093\/rheumatology\/keab524","volume":"60","author":"M Templ\u00e9","year":"2021","unstructured":"Templ\u00e9 M, Duroyon E, Croizier C, Rossignol J, Huet T, Friedrich C et al (2021) Atypical splice-site mutations causing VEXAS syndrome. Rheumatology (Oxford) 60:e435\u2013e437. https:\/\/doi.org\/10.1093\/rheumatology\/keab524","journal-title":"Rheumatology (Oxford)"},{"key":"6338_CR11","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/art.41743","volume":"73","author":"MA Ferrada","year":"2021","unstructured":"Ferrada MA, Sikora KA, Luo Y, Wells KV, Patel B, Groarke EM et al (2021) Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS. Arthritis Rheumatol 73:1886\u20131895. https:\/\/doi.org\/10.1002\/art.41743","journal-title":"Arthritis Rheumatol"},{"key":"6338_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.seminhematol.2021.09.001","volume":"58","author":"M Heiblig","year":"2021","unstructured":"Heiblig M, Patel BA, Groarke EM, Bourbon E, Sujobert P (2021) Toward a pathophysiology inspired treatment of VEXAS syndrome. Semin Hematol 58:239\u2013246. https:\/\/doi.org\/10.1053\/j.seminhematol.2021.09.001","journal-title":"Semin Hematol"},{"key":"6338_CR13","doi-asserted-by":"publisher","unstructured":"Beck DB, Werner A, Kastner DL, Aksentijevich I (2022) Disorders of ubiquitylation: unchained inflammation. Nat Rev Rheumatol:1\u201313. https:\/\/doi.org\/10.1038\/s41584-022-00778-4","DOI":"10.1038\/s41584-022-00778-4"},{"key":"6338_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.seminhematol.2021.10.002","volume":"58","author":"MJ Koster","year":"2021","unstructured":"Koster MJ, Warrington KJ (2021) VEXAS within the spectrum of rheumatologic disease. Semin Hematol 58:218\u2013225. https:\/\/doi.org\/10.1053\/j.seminhematol.2021.10.002","journal-title":"Semin Hematol"},{"key":"6338_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20805","author":"S Georgin-Lavialle","year":"2021","unstructured":"Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E et al (2021) Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.20805","journal-title":"Br J Dermatol"},{"key":"6338_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220089","author":"N Tsuchida","year":"2021","unstructured":"Tsuchida N, Kunishita Y, Uchiyama Y, Kirino Y, Enaka M, Yamaguchi Y et al (2021) Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220089","journal-title":"Ann Rheum Dis"},{"key":"6338_CR17","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","volume":"5","author":"IE Obiorah","year":"2021","unstructured":"Obiorah IE, Patel BA, Groarke EM, Wang W, Trick M, Ombrello AK et al (2021) Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv 5:3203\u20133215. https:\/\/doi.org\/10.1182\/bloodadvances.2021004976","journal-title":"Blood Adv"},{"key":"6338_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1053\/j.seminhematol.2021.10.007","volume":"58","author":"N Patel","year":"2021","unstructured":"Patel N, Dulau-Florea A, Calvo KR (2021) Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome. Semin Hematol 58:204\u2013211. https:\/\/doi.org\/10.1053\/j.seminhematol.2021.10.007","journal-title":"Semin Hematol"},{"key":"6338_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/bjh.17679","volume":"195","author":"V Lacombe","year":"2021","unstructured":"Lacombe V, Prevost M, Bouvier A, Th\u00e9pot S, Chabrun F, Kosmider O et al (2021) Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold. Br J Haematol 195:286\u2013289. https:\/\/doi.org\/10.1111\/bjh.17679","journal-title":"Br J Haematol"},{"key":"6338_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41409-021-01544-y","volume":"57","author":"M Loschi","year":"2022","unstructured":"Loschi M, Roux C, Sudaka I, Ferrero-Vacher C, Marceau-Renaut A, Duployez N et al (2022) Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report. Bone Marrow Transplant 57:315\u2013318. https:\/\/doi.org\/10.1038\/s41409-021-01544-y","journal-title":"Bone Marrow Transplant"},{"key":"6338_CR21","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1182\/blood.2020010177","volume":"137","author":"E Bourbon","year":"2021","unstructured":"Bourbon E, Heiblig M, Gerfaud Valentin M, Barba T, Durel CA, Lega JC et al (2021) Therapeutic options in VEXAS syndrome: insights from a retrospective series. Blood 137:3682\u20133684. https:\/\/doi.org\/10.1182\/blood.2020010177","journal-title":"Blood"},{"key":"6338_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/hs9.0000000000000661","volume":"5","author":"M Raaijmakers","year":"2021","unstructured":"Raaijmakers M, Hermans M, Aalbers A, Rijken M, Dalm V, van Daele P et al (2021) Azacytidine treatment for VEXAS syndrome. Hemasphere 5:e661. https:\/\/doi.org\/10.1097\/hs9.0000000000000661","journal-title":"Hemasphere"},{"key":"6338_CR23","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/bjh.17893","volume":"196","author":"T Comont","year":"2022","unstructured":"Comont T, Heiblig M, Rivi\u00e8re E, Terriou L, Rossignol J, Bouscary D et al (2022) Azacitidine for patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry. Br J Haematol 196:969\u2013974. https:\/\/doi.org\/10.1111\/bjh.17893","journal-title":"Br J Haematol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06338-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T09:17:19Z","timestamp":1665739039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06338-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,20]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["6338"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06338-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,20]]},"assertion":[{"value":"13 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication has been obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}